文献速递心血管CT

急诊科冠状动脉CT血管成像后非阻塞性冠心病的预防性管理

Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-07-17

研究评估急诊科CCTA检出非阻塞性冠心病(1%–49%狭窄)后的医疗管理。510例非阻塞性CAD与510例对照相比,他汀处方率从38.8%升至56.1%(对照组18.0%升至20.4%),多变量分析相对差异7.1倍。但30.0%的10年ASCVD风险≥20%的非阻塞性CAD患者随访结束时未获他汀处方。

要点

  • 急诊CCTA检出1%–49%狭窄的非阻塞性CAD后他汀处方率由38.8%升至56.1%。
  • 30.0%的10年ASCVD风险≥20%的非阻塞性CAD患者随访结束时仍未获他汀处方。
  • 心脏病专科医师评估与非阻塞性CAD患者他汀处方独立相关(OR 4.4)。

核心结论

  • 急诊CCTA偶然发现的亚临床动脉粥样硬化增加了他汀处方的可能性,但改善指定预防性治疗分配的机会仍然存在。

研究设计与样本

  • 研究纳入2013年11月至2018年3月在本院急诊科接受CCTA且在本医疗系统内接受初级保健的患者,非阻塞性CAD定义为CCTA最大管腔狭窄1%至49%,按1例:1对照匹配无CAD对照组,共510例非阻塞性CAD患者和510例对照。

诊断标准与关键数值

  • 非阻塞性CAD定义为CCTA最大管腔狭窄1%至49%;CCTA前10年ASCVD风险采用Pooled Cohort Equations估算;冠脉数据报告与数据系统1至2类结果与平均1.9年随访时低密度脂蛋白胆固醇降低12.1 mg/dl相关(p < 0.001)。

临床应用与阅片要点

  • 急诊CCTA报告非阻塞性CAD(1%–49%狭窄)时,应同时关注患者的10年ASCVD风险评估,因为该结果与后续他汀处方增加相关,但仍有30.0%的高风险患者未获他汀处方。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to assess medical management of patients found to have nonobstructive coronary artery disease (CAD) on coronary computed tomography angiography (CCTA) performed in the emergency department (ED).

BACKGROUND: Contemporary recognition and management of nonobstructive CAD discovered on CCTA performed in the ED is unknown.

METHODS: Patients undergoing CCTA in the authors' hospital's ED between November 2013 and March 2018 who also received primary care within the authors' health system were studied. All patients with nonobstructive CAD, defined as 1% to 49% maximum luminal stenosis on CCTA, were included, along with a control group without CAD in a 1 case:1 control fashion. Ten-year atherosclerotic cardiovascular disease (ASCVD) risk prior to CCTA was estimated using the Pooled Cohort Equations. Management changes were recorded until 6 months after CCTA. Multivariate logistic regression tested the association between CCTA result and follow-up statin prescription, adjusting for cardiovascular risk factors and baseline statin use.

RESULTS: The cohort included 510 patients with nonobstructive CAD and 510 controls. Prevalence of statin prescription increased from 38.8% to 56.1% among patients with nonobstructive CAD (p < 0.001) and 18.0% to 20.4% among controls (p = 0.01), representing a 7.1-fold relative difference (95% confidence interval [CI]: 4.4 to 23.0; p < 0.001) in multivariate analysis. However, 30.0% of patients with nonobstructive CAD and ≥20% 10-year ASCVD risk were not prescribed a statin at the end of follow-up. Cardiologist evaluation was independently associated with statin prescription after adjustment for ASCVD risk factors (odds ratio [OR] 4.4; 95% CI: 2.4 to 8.5; p < 0.001). A Coronary Artery Disease Reporting and Data System class 1 to 2 result was associated with lower low-density lipoprotein cholesterol by 12.1 mg/dl at mean 1.9-year follow-up (p < 0.001).

CONCLUSIONS: Incidental subclinical atherosclerosis on CCTA performed in the ED increases the likelihood of statin prescription, but opportunities to improve allocation of indicated preventive therapies remain.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Honigberg MC, Lander BS, Baliyan V, et al. Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department. JACC Cardiovasc Imaging. 2019. PMID: 31326481. doi:10.1016/j.jcmg.2019.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。